IMMUNOFORGE CO.,LTD.
2Patents
2Active
2Granted
41Portfolio score
Filing activity: May 27, 2016 → Oct 15, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10751392B2 | Pharmaceutical composition for treating sarcopenia including glucagon-like peptide-1 receptor agonist | Human Necessities | 0 | Active |
| US10993993B2 | Pharmaceutical composition for treating muscle atrophy or sarcopenia including glucagon-like peptide (GLP-1) or GLP-1 receptor agonist | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.